Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow’s Gamaleya Institute. It has now approved a third coronavirus vaccine for domestic use.
Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labelled CoviVac and produced by the Chumakov Centre, have yet to begin.
Sputnik V was approved in August and late-stage trials began in September. Mass vaccination was launched in December, showing the vaccine to be 91.4% effective. The PM further added that Russia is the only country to have already three vaccines against COVID-19.
The CoviVac shot is given in two doses, 14 days apart. It is transported and stored at normal fridge temperatures, of 2 to 8 degrees Celsius (35.6 to 46.4 Fahrenheit), Deputy Prime Minister Tatiana Golikova said in a government briefing in January.
Report by Chetali S M
Reported on – 21/02/2021